Jason B Harris
- Massachusetts General Hospital · Microbiology & Immunology (topic-inferred)
- Massachusetts General Hospital · Internal Medicine (topic-inferred)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #5,248
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7566635Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$2M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#5,248
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Jason B Harris as a PI. Multi-PI records show the full award amount for context.
- 1R01AI179917-01A1R01Contact PIVaccine- and infection-derived correlates of protection for choleraMassachusetts General Hospital · Microbiology & Immunology (topic-inferred)$733.7Kaward amount
- 1R01AI175345-01A1R01Contact PIAntibody mediated immunity against Klebsiella pneumoniaeMassachusetts General Hospital · Microbiology & Immunology (topic-inferred)$730.3Kaward amount
- 5R01HD102540-04R01Contact PISingle dose azithromycin to prevent cholera in childrenMassachusetts General Hospital · Internal Medicine (topic-inferred)$552Kaward amount
Award organization
Organizations that administered FY2024 awards listing Jason B Harris as a PI.
FY2024 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5248
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding